Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 48, Issue 7 (Jul 2010)

Issues

Clinical implication of plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis

Constantinos Giaginis
  • Department of Forensic Medicine and Toxicology, Medical School, University of Athens, Athens, Greece
/ Athina Zira
  • Department of Forensic Medicine and Toxicology, Medical School, University of Athens, Athens, Greece
/ Athanasios Katsargyris
  • First Department of Surgery, Laikon Hospital, Medical School, University of Athens, Athens, Greece
/ Chris Klonaris
  • First Department of Surgery, Laikon Hospital, Medical School, University of Athens, Athens, Greece
/ Stamatios Theocharis
  • Department of Forensic Medicine and Toxicology, Medical School, University of Athens, Athens, Greece
Published Online: 2010-04-21 | DOI: https://doi.org/10.1515/CCLM.2010.211

Abstract

Background: Neutrophil gelatinase-associated lipocalin (NGAL) is well established as an early and specific biomarker of kidney disease. Recent evidence further suggests that NGAL may play a crucial role in vascular remodeling and plaque instability during the development of atherosclerosis.

Methods: Plasma NGAL concentrations measured using a solid-phase enzyme-linked immunosorbent assay (ELISA) were correlated with medical history, risk factors and medication intake in 141 patients with advanced carotid atherosclerotic lesions who underwent carotid endarterectomy for vascular repair.

Results: Plasma NGAL concentrations were associated with patient age (Rs=0.2055, p=0.0144), plasma homocysteine (Rs=0.4274, p<0.00001) and serum creatinine (Rs=0.4640, p<0.00001) concentrations and estimated glomerular filtration rate (eGFR) (Rs=−0.4911, p<0.00001). Hypertensive patients, as well as those receiving therapy with angiotensin converting enzyme (ACE) inhibitors, presented with significantly enhanced plasma NGAL concentrations when compared to normotensive (p=0.0341) patients and those not treated (p=0.0004). Enhanced NGAL concentrations did not meet statistical significance for patients with advanced stenosis grade (p=0.0971) or a history of peripheral artery disease (p=0.0827). Multiple regression analysis identified homocysteine, creatinine, eGFR and treatment with ACE inhibitors (p=0.0019, <0.00001, 0.0005 and 0.0219, respectively) as independent predictors of NGAL concentration.

Conclusions: Plasma NGAL concentrations were associated with patient age, hypertension, eGFR, creatinine and homocysteine concentrations and therapy with ACE inhibitors. The role of NGAL in the development of atherosclerosis needs to be further explored taking into consideration the uncontrolled effect of renal disease in atherosclerotic patients with multiple risk factors.

Clin Chem Lab Med 2010;48:1035–41.

Keywords: atherosclerosis; carotid; medical history; NGAL; risk factors

About the article

Corresponding author: Stamatios Theocharis, MD, PhD, Assistant Professor of Forensic Medicine and Toxicology, University of Athens, Medical School, 75, M. Asias street, Goudi, Athens, 11527, Greece Phone: +30 210 7462413, Fax: +30 210 7716098,


Received: 2009-11-13

Accepted: 2010-02-02

Published Online: 2010-04-21

Published in Print: 2010-07-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2010.211.

Export Citation

©2010 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Comments (0)

Please log in or register to comment.
Log in